Govern Reputation Like the Asset It Is
Most boards govern reputation after the fact. Crisis playbooks. Brand monitoring. Compliance reporting. Standing oversight of damage already done.
That instinct is sound but incomplete. Across two decades governing growth in regulated environments, including current service as a board director and committee chair in senior living and as an advisor to an AI-enabled decision risk platform, the pattern is consistent: in industries where trust is required to create lasting customer relationships, reputation is also an enterprise asset that compounds growth. The asset side of that ledger usually goes unmanaged at the board level. That is a gap in fiduciary oversight, not a gap in marketing.
Trust erodes at the speed of a screenshot. It rebuilds at the speed it always did. Boards govern in the gap between them.
Why this matters more for private company boards
Public companies have daily share price discipline. Reputational erosion shows up quickly in stock price, media coverage, and investor commentary.
Private companies have none of that.
Reputational erosion in a family business, a private equity-owned operating company, or an ESOP often hides until it surfaces when the company is trying to raise capital, close a deal, or retain a major customer. By then the damage is done and there is little time to respond. A private company can lose meaningful value without a single board meeting agenda flagging it, because the metrics that would raise it as an issue are not on the board agenda.
Private companies often carry more reputational exposure than public ones. Fewer but major customer relationships. The challenge to hire key talent in a tight labor market. For family businesses, the family name itself. For ESOPs, the trust of employee-owners whose retirement assets sit inside the company. For private equity portfolio companies, the reputation that supports exit multiples.
When reputation is doing this much economic work, governing as a lagging indicator is not full oversight.
The pace of reputation has changed. A misaligned statement, an internal email made public, or a single customer’s story going viral can compress a quarter of reputational impact into an afternoon. That asymmetry is what makes this fiduciary territory now in a way it wasn’t a decade ago.
The fiduciary case
NACD’s 2025 Governance Outlook put the framing directly: “Traditional board accountabilities—capital allocation, long-term strategy, risk oversight, compliance, and succession planning—are now simply table stakes. They are necessary but no longer sufficient requirements for managing risks to reputation.”1
Extend that argument one step further. Director oversight doesn’t end at preventing harm. The duty of care extends to overseeing how the enterprise creates value. When an asset materially affects customer acquisition, talent recruitment, regulatory standing, and innovation, a board is leaving real value on the table.
The 2024 Edelman Trust Barometer found that business is now the most trusted institution globally, but that trust is conditional, with sixty-one percent of respondents worried that business leaders are deliberately misleading.2 Trust is harder to earn, easier to lose, and increasingly the variable that determines whether a private company grows into its strategy or doesn’t.
Three shifts when boards take this seriously
Three changes signal that a board is governing reputation as an asset, not only as a risk.
- Reputation moves from postmortem to standing oversight. Trust signals belong on the regular governance cadence: customer sentiment trends, employee belief in the brand, partner and channel retention, complaint patterns. Inputs to forward decisions, not retrospectives.
- Director slates close the brand-and-growth competence gap. In healthcare, AI-enabled industries, financial services, and other trust-dependent sectors, the gap surfaces during nominating and governance committee work. PwC’s 2025 Annual Corporate Directors Survey found that only thirty-two percent of executives believe their boards have the right mix of skills and expertise.3 A director who has built or rebuilt trust at scale in a regulated environment is doing the work the board needs done.
- Innovation gets governed against a trust ledger. Innovation in regulated industries fails when it outruns trust. Boards that govern reputation as growth capital ask of every initiative: does this build the trust the company will need for the next decision, or does it erode it? That question changes what escalates for board review.
Ethics and growth aren’t a tradeoff
In trust-dependent industries, ethics and growth drive the same growth.
A senior living operator that aligns incentives, culture, and brand promise grows because residents and families trust the system when stakes are highest. A healthcare technology company that earns clinician confidence grows because adoption depends on it. A specialty manufacturer that proves it does what it says grows because purchasers stop assuming the worst.
The growth case and the ethics case point in the same direction. The board’s role is keeping them aligned. Ethics, governed well, is what makes growth durable. Erode trust and it shows in stalling growth and hiring. Keep it aligned and it compounds over time. NACD has framed the same point in governance terms: boards need to ground themselves in the firm’s mission, purpose, and values as integral to current and future business, not as concerns adjacent to it.4
Committee-level work
This is where the argument becomes operational. Three committees carry most of the load.
- Audit and risk committees expand the oversight dashboard beyond lagging indicators. Customer sentiment trends, employee engagement gaps, complaint patterns, and investor sentiment belong on a regular cadence alongside financial outcomes and regulatory inquiries. At a private company, the owner or CEO often knows when a major customer isn’t going to renew. The challenge is institutionalizing that knowledge into the board record.
- Nominating and governance committees treat brand and growth competence as a recruiting priority. Board refreshment is driven by what the company faces next, not by who is rotating off. PE-owned boards match director skill mix to the value-creation plan and the planned exit window. Family business boards bring in independent directors with reputation expertise to support the next generation. ESOP boards account for the fact that employee-owners are also the brand’s most influential ambassadors.
- Compensation committees test whether executive incentives match what the company says it is building. If the brand promise is trust-led and the comp plan is short-term financial only, the gap is visible to employees first, customers next, and the market eventually. In a private company, where there is no proxy advisor watching, the pressure to align incentives with values has to come from within the boardroom.
Where this gets hard in private company contexts
Patterns recur across private equity, family, and ESOP boards.
PE-owned companies often emphasize financial and operational levers along the path to exit, and reputation appears on the agenda only when something goes wrong or a crisis emerges. Exit multiples respond to reputation among buyers, customers, and talent. A portfolio company that erodes reputation during the hold period exits at a discount. In a tight fundraising environment, limited partners notice the firms that leave a trail of trust-eroded exits and the ones that don’t.
Family businesses carry the family name as a reputational asset, often the most valuable one on the balance sheet. Independent directors play a particular role in helping the family see reputation choices objectively, including moments when family members and brand are not aligned.
ESOP boards face a different overlap. Employee-owners are simultaneously the workforce, the brand’s daily ambassadors, and the company’s shareholders of record. Reputation governance and culture governance run together, and the board oversees both as a single asset. Compensation alignment matters even more in this context. Incentive misalignment is not only visible to employees; they feel it directly as owners.
Founder-led private companies face a third dynamic. The founder is often the brand. Boards in this setting oversee both the company’s reputation and the careful work of building enterprise reputation that doesn’t depend entirely on one person. That work is succession planning at the same time it is reputation governance. The two all too often get treated separately. They shouldn’t be. The risk surfaces sharply in any leadership transition, planned or unplanned, when the company has to demonstrate that its reputation belongs to the institution and not the individual.
Questions for the boardroom
Five questions worth taking up at the committee and full-board level:
- Does our oversight dashboard tell us whether we are building or eroding our reputational capital?
- When we sponsor innovation, are we asking what it costs in trust?
- Are our incentives aligned to what we say we are building?
- Is our crisis playbook matched by a growth playbook for reputation?
- Does our board composition reflect the strategic decisions ahead?
Where boards should start
The argument applies across private company types, with adjustments by ownership structure.
For PE-owned companies, reputation governance ties directly to the value-creation plan.
Family businesses face multi-generational stewardship of the family name.
In an ESOP, reputation governance and culture governance are the same work.
Founder-led companies need institutional resilience planning embedded in reputation governance.
The question that frames the work:
Is reputation on our board's agenda as an asset we govern, or only as a risk we monitor?
Boards that bring that question into every consequential decision compound the asset. The ones that ask it only after the fact are still working in the rearview.
ABOUT THE AUTHOR
Melissa Fors Shackelford is a healthcare executive, board director, and growth strategist with more than two decades of experience scaling brands and enterprises across Fortune 50 organizations, national behavioral health systems, and high-growth digital health companies. She chairs the Nominating and Governance Committee at Asbury Communities and serves on the advisory board of Insperai, an AI-enabled decision risk intelligence company. Her executive background includes senior roles at Optum, Cigna/Express Scripts, and Hazelden Betty Ford. She is on the faculty of Women Business Leaders and the AHA Society for Strategy and Market Development Advisory Board. She holds an MBA from the University of St. Thomas and is an NACD Certified Director.